n-acetylaspartic acid has been researched along with Cognitive Decline in 35 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 29 (82.86) | 24.3611 |
| 2020's | 6 (17.14) | 2.80 |
| Authors | Studies |
|---|---|
| Cordato, DJ; Shad, KF; Soubra, W | 1 |
| Chitty, K; Haber, PS; Lagopoulos, J; Logge, W; Morley, KC; Moustafa, AA | 1 |
| Hong, Q; Li, S; Lian, X; Yin, C; Zhao, W | 1 |
| Atiya, S; Bartha, R; Borrie, MJ; Brymer, C; Fogarty, J; Montero-Odasso, M; Pasternak, SH; Wong, D | 1 |
| Balcioglu, YH; Sen, M; Yesilkaya, UH | 1 |
| Briemberg, H; Eurich, DT; Frayne, R; Genge, AL; Graham, SJ; Hanstock, C; Ishaque, A; Kalra, S; Korngut, L; Luk, C; Seres, P; Srivastava, O; Ta, D; Zinman, L | 1 |
| Chen, W; Gong, ZK; Sheng, C; Wang, M; Wang, SY; Wang, XX | 1 |
| Moriya, M; Nojo, T; Waragai, M | 1 |
| Denney, TS; Gawne, TJ; Lahti, AC; Reid, MA; Salibi, N; White, DM | 1 |
| Aslan, S; Chen, JR; Choi, C; Khan, DA; Kroll, JL; Patel, SV; Pinkham, AE; Ritz, T; Sherwood Brown, E; Steele, AM | 1 |
| Alakkas, A; Clifford, DB; Collier, A; Ellis, RJ; Fennema-Notestine, C; Gelman, B; Gianella, S; Grant, I; Heaton, RK; Kallianpur, A; Letendre, S; Marcotte, T; Marra, C; McCutchan, JA; Morgello, S; Sacktor, N; Simpson, D; Umlauf, A; Watson, CW | 1 |
| Cai, ZL; Liu, Y; Wu, F; Xue, S; Zhou, X | 1 |
| Kantarci, K | 1 |
| Andrade-Valença, LP; Menezes, TL; Valença, MM | 1 |
| Aleman, A; Martens, S; Tumati, S | 1 |
| Alvarez-Linera, J; Frank, A; García-Álvarez, R; Hernández-Tamames, JA; Loureiro, JP; Mato Abad, V; Quirós, A | 1 |
| Sukying, C; Suriyajakryuththana, W; Teepprasarn, N; Tuntiyatorn, L | 1 |
| Amann, M; Babb, JS; Gass, A; Glodzik, L; Gokhale, A; Gonen, O; Hirsch, JG; Monsch, AU; Rusinek, H; Sollberger, M | 1 |
| Akiguchi, I; Shiino, A; Watanabe, T | 1 |
| Almuqbel, M; Anderson, TJ; Dalrymple-Alford, JC; Keenan, RJ; Livingston, L; MacAskill, MR; Melzer, TR; Myall, DJ; Pitcher, TL; Wood, KL | 1 |
| Anderson, PJ; Bainbridge, A; Burnett, AC; Cheong, JL; Doyle, LW; Lee, KJ; Roberts, G; Robertson, NJ; Thompson, DK; Wood, SJ | 1 |
| Meng, N; Shi, S; Su, Y | 1 |
| Chen, W; Chen, X; Guo, Z; Hou, H; Liu, X; Shen, Y; Wei, F | 1 |
| Hwang, J; Jeon, S; Kang, I; Kim, B; Kim, GH; Kim, JE; Kim, JY; Lyoo, IK; Ma, J; Renshaw, PF; Yoon, S; Yurgelun-Todd, DA | 1 |
| Bulik, M; Burkon, P; Dobiaskova, M; Hynkova, L; Jancalek, R; Kazda, T; Laack, NN; Pospisil, P; Slampa, P | 1 |
| Daly, EM; Foy, CM; Glover, A; Lovestone, S; Murphy, DG; O'Gorman, R; Simmons, A | 1 |
| Chen, K; Ding, B; Fang, Y; Li, X; Ling, H; Wang, T; Xiao, S | 1 |
| Arlt, S; Block, W; Ende, G; Frölich, L; Gür, O; Hammen, T; Jessen, F; Kornhuber, J; Kucinski, T; Lewczuk, P; Maier, W; Peters, O; Popp, J; Träber, F; Wiltfang, J | 1 |
| Aguilar, K; Fayed, N; Modrego, PJ; Rojas-Salinas, G | 1 |
| Barcikowska, M; Ćwikła, JB; Gabryelewicz, T; Walecki, J | 1 |
| Andreiuolo, PA; Bottino, CM; de Oliveira-Souza, R; Moll, J; Silveira de Souza, A; Tovar-Moll, F | 1 |
| Fayed, N; Modrego, PJ | 1 |
| Choi, JY; Hong, YH; Kim, HS; Lim, TS; Moon, SY | 1 |
| Delfino, M; García-Sánchez, C; Gironell, A; Gómez-Ansón, B; Kulisevsky, J; Llebaria, G; Pagonabarraga, J; Pascual-Sedano, B; Rotger, R; Ruscalleda, J | 1 |
| Gan, R; Huang, B; Huang, Z; Nie, K; Wang, L; Zhang, Y; Zhao, J | 1 |
2 review(s) available for n-acetylaspartic acid and Cognitive Decline
| Article | Year |
|---|---|
Proton MRS in mild cognitive impairment.
Topics: Alzheimer Disease; Animals; Aspartic Acid; Biomarkers; Brain; Choline; Cognitive Dysfunction; Creatine; Dementia; Diagnosis, Differential; Disease Models, Animal; Disease Progression; Energy Metabolism; Humans; Inositol; Magnetic Resonance Spectroscopy; Mice; Translational Research, Biomedical | 2013 |
Magnetic resonance spectroscopy in mild cognitive impairment: systematic review and meta-analysis.
Topics: Aspartic Acid; Choline; Cognitive Dysfunction; Creatine; Humans; Inositol; Magnetic Resonance Spectroscopy | 2013 |
33 other study(ies) available for n-acetylaspartic acid and Cognitive Decline
| Article | Year |
|---|---|
The Auditory Afferent Pathway as a Clinical Marker of Alzheimer's Disease.
Topics: Acoustic Stimulation; Afferent Pathways; Aged; Alzheimer Disease; Aspartic Acid; Biomarkers; Cerebral Cortex; Cognitive Dysfunction; Creatine; Electroencephalography; Evoked Potentials, Auditory; Female; Humans; Inositol; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Mental Status and Dementia Tests; Middle Aged; Temporal Lobe | 2022 |
Brain N-Acetyl Aspartate and associations with cognitive impairment in alcohol dependent patients.
Topics: Adult; Aged; Alcoholism; Aspartic Acid; Brain Chemistry; Cognitive Dysfunction; Female; Humans; Magnetic Resonance Spectroscopy; Male; Mental Status and Dementia Tests; Middle Aged; Neuropsychological Tests; Parietal Lobe; Risk-Taking; Trail Making Test | 2020 |
Application of Hydrogen Proton Magnetic Resonance Technology Combined with Brain Neurometabolite Analysis in the Treatment of Cognitive Impairment Caused by Type 2 Diabetes Mellitus.
Topics: Adult; Aged; Aspartic Acid; Cognitive Dysfunction; Diabetes Mellitus, Type 2; Female; Humans; Hydrogen; Male; Middle Aged; Prefrontal Cortex; Proton Magnetic Resonance Spectroscopy; Protons; Treatment Outcome | 2020 |
Reduced Hippocampal Glutamate and Posterior Cingulate N-Acetyl Aspartate in Mild Cognitive Impairment and Alzheimer's Disease Is Associated with Episodic Memory Performance and White Matter Integrity in the Cingulum: A Pilot Study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aspartic Acid; Cognitive Dysfunction; Diffusion Tensor Imaging; Female; Glutamic Acid; Gyrus Cinguli; Hippocampus; Humans; Limbic System; Magnetic Resonance Spectroscopy; Male; Memory, Episodic; Mental Status and Dementia Tests; Middle Aged; Neuropsychological Tests; Pilot Projects; White Matter | 2020 |
COVID-19-related cognitive dysfunction may be associated with transient disruption in the DLPFC glutamatergic pathway.
Topics: Adult; Aspartic Acid; Cognitive Dysfunction; COVID-19; Glutamic Acid; Humans; Magnetic Resonance Spectroscopy; Male; Prefrontal Cortex; Signal Transduction | 2021 |
Progressive Neurochemical Abnormalities in Cognitive and Motor Subgroups of Amyotrophic Lateral Sclerosis: A Prospective Multicenter Study.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Cognitive Dysfunction; Disease Progression; Female; Humans; Longitudinal Studies; Magnetic Resonance Spectroscopy; Male; Middle Aged; Motor Cortex; Prefrontal Cortex; Severity of Illness Index | 2021 |
Study on the clinical application of the MRS in the cognitive assessment after stroke.
Topics: Aspartic Acid; Cognition; Cognition Disorders; Cognitive Dysfunction; Creatine; Hippocampus; Humans; Magnetic Resonance Spectroscopy; Stroke | 2017 |
Decreased N-Acetyl Aspartate/Myo-Inositol Ratio in the Posterior Cingulate Cortex Shown by Magnetic Resonance Spectroscopy May Be One of the Risk Markers of Preclinical Alzheimer's Disease: A 7-Year Follow-Up Study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aspartic Acid; Biomarkers; Cognitive Dysfunction; Disease Progression; Female; Follow-Up Studies; Gyrus Cinguli; Humans; Inositol; Lewy Body Disease; Male; Mental Status and Dementia Tests; Parkinson Disease; Prodromal Symptoms; Proton Magnetic Resonance Spectroscopy; Retrospective Studies; Risk Factors | 2017 |
7T Proton Magnetic Resonance Spectroscopy of the Anterior Cingulate Cortex in First-Episode Schizophrenia.
Topics: Adult; Aspartic Acid; Cognitive Dysfunction; Female; gamma-Aminobutyric Acid; Glutamic Acid; Gyrus Cinguli; Humans; Male; Proton Magnetic Resonance Spectroscopy; Psychotic Disorders; Schizophrenia; Young Adult | 2019 |
Hippocampal metabolites in asthma and their implications for cognitive function.
Topics: Adolescent; Adult; Aspartic Acid; Asthma; Cognition; Cognitive Dysfunction; Creatine; Female; Glutamic Acid; Hippocampus; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Young Adult | 2018 |
White matter damage, neuroinflammation, and neuronal integrity in HAND.
Topics: Adult; AIDS Dementia Complex; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Aspartic Acid; Basal Ganglia; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Choline; Cognitive Dysfunction; Creatine; Female; Gray Matter; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Memory, Short-Term; Middle Aged; Neuroimaging; Neuropsychological Tests; Organ Size; Severity of Illness Index; White Matter | 2019 |
Proxies of cognitive reserve and their effects on neuropsychological performance in patients with mild cognitive impairment.
Topics: Aged; Aged, 80 and over; Aspartic Acid; Biomarkers; Choline; Cognitive Dysfunction; Cognitive Reserve; Creatine; Diagnostic and Statistical Manual of Mental Disorders; Educational Status; Female; Hippocampus; Humans; Inositol; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Memory; Middle Aged; Neuropsychological Tests; Psychomotor Performance; Wechsler Scales | 2013 |
Magnetic resonance imaging study cannot individually distinguish individuals with mild cognitive impairment, mild Alzheimer's disease, and normal aging.
Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Aspartic Acid; Choline; Cognitive Dysfunction; Diagnosis, Differential; Female; Hippocampus; Humans; Inositol; Magnetic Resonance Imaging; Male; Mental Status Schedule; Severity of Illness Index | 2013 |
The partial volume effect in the quantification of 1H magnetic resonance spectroscopy in Alzheimer's disease and aging.
Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Analysis of Variance; Aspartic Acid; Brain; Cognitive Dysfunction; Female; Functional Laterality; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Protons | 2014 |
Proton magnetic resonance spectroscopy in mild cognitive impairment and Alzheimer's disease: a preliminary study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aspartic Acid; Case-Control Studies; Choline; Cognitive Dysfunction; Creatine; Cross-Sectional Studies; Female; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Middle Aged | 2014 |
Global N-acetylaspartate in normal subjects, mild cognitive impairment and Alzheimer's disease patients.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aspartic Acid; Biomarkers; Brain; Cognitive Dysfunction; Female; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Sensitivity and Specificity | 2015 |
[Prediction of conversion from amnestic mild cognitive impairment to Alzheimer's disease using proton magnetic resonance spectroscopy].
Topics: Aged; Alzheimer Disease; Amnesia; Aspartic Acid; Cognitive Dysfunction; Disease Progression; Female; Forecasting; Hippocampus; Humans; Male; Proton Magnetic Resonance Spectroscopy | 2015 |
Metabolite ratios in the posterior cingulate cortex do not track cognitive decline in Parkinson's disease in a clinical setting.
Topics: Aged; Aged, 80 and over; Aspartic Acid; Bayes Theorem; Case-Control Studies; Choline; Cognitive Dysfunction; Creatine; Dementia; Disease Progression; Female; Gyrus Cinguli; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Superior Sagittal Sinus | 2016 |
Altered posterior cingulate brain metabolites and cognitive dysfunction in preterm adolescents.
Topics: Adolescent; Aspartic Acid; Australia; Brain; Cell Membrane; Choline; Cognition; Cognition Disorders; Cognitive Dysfunction; Creatinine; Female; Gyrus Cinguli; Humans; Infant, Premature; Magnetic Resonance Spectroscopy; Male; Neurons; Prospective Studies; Regression Analysis; Treatment Outcome | 2016 |
Proton magnetic resonance spectroscopy as a diagnostic biomarker in mild cognitive impairment following stroke in acute phase.
Topics: Aged; Aspartic Acid; Biomarkers; Cognitive Dysfunction; Creatine; Female; Hippocampus; Humans; Male; Middle Aged; Proton Magnetic Resonance Spectroscopy; Stroke | 2016 |
(1)H-MRS asymmetry changes in the anterior and posterior cingulate gyrus in patients with mild cognitive impairment and mild Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Aspartic Acid; Choline; Cognitive Dysfunction; Creatine; Dominance, Cerebral; Female; Gyrus Cinguli; Humans; Inositol; Male; Middle Aged; Proton Magnetic Resonance Spectroscopy | 2016 |
Metabolic alterations in the anterior cingulate cortex and related cognitive deficits in late adolescent methamphetamine users.
Topics: Adolescent; Amphetamine-Related Disorders; Aspartic Acid; Brain; Case-Control Studies; Cognitive Dysfunction; Female; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Male; Methamphetamine; Proton Magnetic Resonance Spectroscopy; Stroop Test; Young Adult | 2018 |
Post-WBRT cognitive impairment and hippocampal neuronal depletion measured by in vivo metabolic MR spectroscopy: Results of prospective investigational study.
Topics: Aspartic Acid; Biomarkers; Brain Neoplasms; Cognitive Dysfunction; Cranial Irradiation; Female; Follow-Up Studies; Hippocampus; Humans; Magnetic Resonance Spectroscopy; Male; Memory; Middle Aged; Nerve Degeneration; Neuropsychological Tests; Prospective Studies; Quality of Life; Surveys and Questionnaires | 2017 |
Hippocampal proton MR spectroscopy in early Alzheimer's disease and mild cognitive impairment.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aspartic Acid; Case-Control Studies; Choline; Cognitive Dysfunction; Creatine; Female; Hippocampus; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Phosphocreatine; Protons | 2011 |
Using proton magnetic resonance spectroscopy to identify mild cognitive impairment.
Topics: Aged; Alzheimer Disease; Aspartic Acid; Brain; Case-Control Studies; Choline; Cognitive Dysfunction; Creatine; Female; Gyrus Cinguli; Hippocampus; Humans; Inositol; Magnetic Resonance Imaging; Male; Neuroimaging | 2012 |
Association of N-acetylaspartate and cerebrospinal fluid Aβ42 in dementia.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Aspartic Acid; Biomarkers; Cognitive Dysfunction; Dementia; Female; Humans; Male; Middle Aged; Mitochondria; Neurons; Peptide Fragments | 2011 |
Brain glutamate levels are decreased in Alzheimer's disease: a magnetic resonance spectroscopy study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aspartic Acid; Choline; Cognitive Dysfunction; Creatine; Cross-Sectional Studies; Female; Glutamic Acid; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Protons; Severity of Illness Index | 2011 |
N-acetylaspartate, choline, myoinositol, glutamine and glutamate (glx) concentration changes in proton MR spectroscopy (1H MRS) in patients with mild cognitive impairment (MCI).
Topics: Aged; Alzheimer Disease; Aspartic Acid; Choline; Cognitive Dysfunction; Disease Progression; Female; Glutamic Acid; Glutamine; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Middle Aged; Protons; Temporal Lobe | 2011 |
Contribution of 1H spectroscopy to a brief cognitive-functional test battery for the diagnosis of mild Alzheimer's disease.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Alzheimer Disease; Aspartic Acid; Cognitive Dysfunction; Creatine; Diagnosis, Differential; Female; Gyrus Cinguli; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Mental Status Schedule; Neuropsychological Tests; Parietal Lobe; Predictive Value of Tests; Reference Values; Temporal Lobe | 2011 |
Longitudinal magnetic resonance spectroscopy as marker of cognitive deterioration in mild cognitive impairment.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aspartic Acid; Brain; Cognitive Dysfunction; Creatine; Female; Follow-Up Studies; Humans; Longitudinal Studies; Magnetic Resonance Spectroscopy; Male; Middle Aged | 2011 |
Functional investigation of bilateral posterior cingulate gyri using multivoxel MR spectroscopy.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Alzheimer Disease; Aspartic Acid; Cognitive Dysfunction; Creatine; Female; Functional Laterality; Gyrus Cinguli; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuropsychological Tests; Psychiatric Status Rating Scales; Republic of Korea; Retrospective Studies; Statistics as Topic | 2012 |
Spectroscopic changes associated with mild cognitive impairment and dementia in Parkinson's disease.
Topics: Aged, 80 and over; Aspartic Acid; Brain Chemistry; Cognition; Cognitive Dysfunction; Data Interpretation, Statistical; Dementia; Disease Progression; Executive Function; Female; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Prefrontal Cortex; Psychiatric Status Rating Scales; Psychomotor Performance; Temporal Lobe; Tomography, X-Ray Computed | 2012 |
Marked N-acetylaspartate and choline metabolite changes in Parkinson's disease patients with mild cognitive impairment.
Topics: Aged; Aspartic Acid; Biomarkers; Brain; Brain Chemistry; Choline; Cognitive Dysfunction; Early Diagnosis; Female; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Parkinson Disease | 2013 |